GET THE APP

European Journal of Clinical Oncology

ISSN - 2732-2654

Edie Watson

Editorial office, European Journal of Clinical Oncology, Afghanistan

Publications

  • Opinion   
    An overview of the therapeutic effectiveness and difficulties of nanoparticles in the treatment of blood cancer
    Author(s): Edie Watson*

    Despite enormous advancements in medical science and technology, there are few effective treatments for cancer. Major causes of disability and death include the metastasis and recurrence of cancer. Because conventional cancer treatments have many drawbacks, cancer nanomedicine, also known as cancer nanotechnology, has emerged as a more precise and benign cancer treatment option. Despite enormous advancements in medical science and technology, there are few effective treatments for cancer. Major causes of disability and death include the metastasis and recurrence of cancer. Because conventional cancer treatments have many drawbacks, cancer nanomedicine, also known as cancer nanotechnology, has emerged as a more precise and benign cancer treatment option. Novel nanomaterials stabilised by biomolecules have become well-known next-generation materials in recent years. Nanotechnology advan.. View More»
    DOI: 10.35248/clinical-oncology.23. 5(2).1-2

    Abstract HTML PDF

Top